De Witte Jan 4
4 · INTEGRA LIFESCIENCES HOLDINGS CORP · Filed Mar 13, 2024
Insider Transaction Report
Form 4
De Witte Jan
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2024-03-11$36.22/sh−205$7,425→ 18,350 total - Award
Non- Qualified Stock Option (right to buy)
2024-03-11+95,664→ 95,664 totalExercise: $36.22Exp: 2032-03-11→ Common Stock (95,664 underlying) - Award
Restricted Stock Units
2024-03-11+41,414→ 130,485 totalExercise: $0.00→ Common Stock (41,414 underlying) - Exercise/Conversion
Common Stock
2024-03-11+205→ 18,555 total - Exercise/Conversion
Restricted Stock Units
2024-03-11−205→ 130,280 totalExercise: $0.00→ Common Stock (205 underlying)
Footnotes (3)
- [F1]25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024.
- [F2]The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2024 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.
- [F3]The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 of which the second installment vested on 3/11/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.